Why “reprogramming” is the buzziest approach to reversing aging right now
Biotech companies are increasingly exploring 'reprogramming' cells to reverse aging and treat age-related diseases like glaucoma. While early trials are underway, experts caution that the science is complex and previous trends in aging research have faced setbacks.
Why it matters
Advancements in cellular reprogramming could fundamentally change how medicine treats age-related decline, though the field remains speculative.
Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.
The article balances the excitement of new funding with scientific skepticism.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in